0000899243-20-013102.txt : 20200514 0000899243-20-013102.hdr.sgml : 20200514 20200514170444 ACCESSION NUMBER: 0000899243-20-013102 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200513 FILED AS OF DATE: 20200514 DATE AS OF CHANGE: 20200514 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stueland Katherine CENTRAL INDEX KEY: 0001689575 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36847 FILM NUMBER: 20878787 MAIL ADDRESS: STREET 1: 458 BRANNAN STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94107 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Invitae Corp CENTRAL INDEX KEY: 0001501134 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 271701898 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1400 16TH STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94103 BUSINESS PHONE: (415) 374-7782 MAIL ADDRESS: STREET 1: 1400 16TH STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94103 FORMER COMPANY: FORMER CONFORMED NAME: InVitae Corp DATE OF NAME CHANGE: 20121105 FORMER COMPANY: FORMER CONFORMED NAME: Locus Development Inc DATE OF NAME CHANGE: 20100910 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-05-13 0 0001501134 Invitae Corp NVTA 0001689575 Stueland Katherine C/O INVITAE CORPORATION 1400 16TH STREET SAN FRANCISCO CA 94103 0 1 0 0 Chief Commercial Officer Common Stock 2020-05-13 4 S 0 1000 17.56 D 211102 D These sales of common stock were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 22, 2019. Includes an aggregate of 172,173 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested. /s/ Katherine Stueland 2020-05-14